Ahead of the Curve: How Early Detection of Disability May Impact the MS Disease Course
Integrating Patient Perspectives, Clinical Insights, and Scientific Advances:The understanding of multiple sclerosis is evolving from a clinically defined disease to a dynamic biological continuum. As a result, the spotlight is shifting towards identifying the underlying drivers of disability accumulation as early as possible, with the goal of influencing the disease course. Join the panel to unravel the underlying biological mechanisms of disability accumulation, how these manifest in the patient and gain insights into the importance of recognizing the signs of disability accumulation early.
Note from the speakers
Medical ITU
Speaker Biographies
AAN, American Academy of Neurology; MS, multiple sclerosis. This program is NOT accredited for continuing education by any organization. Additionally, Industry Therapeutic Updates program content and the views expressed herein are those of the presenting corporate entity and not of the AAN. These programs are not an official part of the 2026 AAN Annual Meeting education or scientific programs, nor are they endorsed by the AAN. The AAN cannot affirm claims pertaining to FDA off-label medication, research use of pre-FDA drugs, or other research information that might be discussed. Industry Therapeutic Updates are industry events. This is a non-promotional medical symposium sponsored by Sanofi. The content was developed by Sanofi in consultation with scientific experts and a person living with MS for scientific exchange purposes and is not eligible for CME credits. This event is for HCPs only.